ZoomMed Announces the Filing on Sedar of an Amended Management Proxy Circular

ZoomMed Inc. (TSX VENTURE:ZMD) announces the filing today on SEDAR of an amended
management proxy circular dated November 6, 2012. 


The amendments made to the document are the result of an observation received
from the Autorite des marches financiers du Quebec as part of its continuous
disclosure review program, and were made to ensure its compliance with the
requirements of Regulation 51-102 of the Securities Act. 


The amended document is the management proxy circular dated October 25, 2012
regarding ZoomMed's shareholders meeting to be held November 23, 2012. 


To comply with the new form 51-102F6, the amendments are described below.

In section " Directors and designated executive officers' compensation", we have
added, to the different tables, the information about the stock options which
were granted to all directors as of November 30, 2011 and have reflected the
results of the total compensation associated with it.


The amended document is available for consultation on SEDAR at www.sedar.com. 

FOR FURTHER INFORMATION PLEASE CONTACT: 
Mrs. Marie-Helene Pinard
Vice President Finance and Chief Financial Officer
[phone], Ext 231
[e-mail]
www.zoommed.com